Sofinnova Investments’s Vera Therapeutics VERA Stock Holding History

Sofinnova Investments’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120M	Hold	2,793,987	–	–	6.2%	2
2026 Q1	$112M	Hold	2,793,987	–	–	4.27%	6
2025 Q4	$141M	Hold	2,793,987	–	–	6.1%	4
2025 Q3	$81.2M	Hold	2,793,987	–	–	4.44%	3
2025 Q2	$65.8M	Hold	2,793,987	–	–	4.03%	5
2025 Q1	$67.1M	Hold	2,793,987	–	–	4.38%	5
2024 Q4	$118M	Hold	2,793,987	–	–	8.61%	2
2024 Q3	$123M	Hold	2,793,987	–	–	9.8%	2
2024 Q2	$101M	Hold	2,793,987	–	–	5.25%	3
2024 Q1	$120M	Sell	2,793,987 -673,169	-19%	-$24M	6.71%	2
2023 Q4	$53.3M	Hold	3,467,156	–	–	2.98%	8
2023 Q3	$47.5M	Hold	3,467,156	–	–	3%	10
2023 Q2	$55.6M	Hold	3,467,156	–	–	3.64%	8
2023 Q1	$26.9M	Buy	3,467,156 +285,714	+9%	+$2.21M	1.72%	15
2022 Q4	$61.6M	Hold	3,181,442	–	–	3.65%	8
2022 Q3	$67.8M	Hold	3,181,442	–	–	3.94%	4
2022 Q2	$43.3M	Hold	3,181,442	–	–	3.61%	6
2022 Q1	$74.7M	Buy	3,181,442 +266,666	+9%	+$5.74M	5.67%	4
2021 Q4	$77.9M	Hold	2,914,776	–	–	4.55%	3
2021 Q3	$50.6M	Hold	2,914,776	–	–	2.99%	7
2021 Q2	$38.6M	Buy	+2,914,776	New	+$45.3M	2.23%	10

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sofinnova Investments's VERA Position: Q2 2026 in Review

Sofinnova Investments held its Vera Therapeutics (VERA) position steady in Q2 2026 at 2,793,987 shares worth $120M. The position accounts for 6.2% of the portfolio, ranked #2.

Sofinnova Investments first reported a position in VERA in Q2 2021 and has held it in 21 quarters since. The position peaked at $141M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Sofinnova Investments held 2,793,987 shares of Vera Therapeutics worth $120M as of Q2 2026.
Sofinnova Investments left its Vera Therapeutics share count unchanged in Q2 2026.
Vera Therapeutics made up 6.2% of Sofinnova Investments's portfolio in Q2 2026, its #2 holding.
Sofinnova Investments first reported a position in Vera Therapeutics in Q2 2021 and has held it in 21 quarters since.
Sofinnova Investments's Vera Therapeutics position peaked at $141M in Q4 2025.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.